Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Phibro Animal Health (PAHC) Shares Outstanding (2016 - 2026)

Phibro Animal Health has reported Shares Outstanding over the past 13 years, most recently at $20.0 million for Q4 2025.

  • For Q4 2025, Shares Outstanding fell 50.72% year-over-year to $20.0 million; the TTM value through Dec 2025 reached $20.0 million, down 50.72%, while the annual FY2025 figure was $20.4 million, 49.71% down from the prior year.
  • Shares Outstanding for Q4 2025 was $40.5 million at Phibro Animal Health, roughly flat from $40.5 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $40.5 million in Q4 2025 and troughed at $20.2 million in Q2 2025.
  • A 5-year average of $38.5 million and a median of $40.5 million in 2021 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: grew 0.12% in 2021 and later crashed 50.72% in 2025.
  • Year by year, Shares Outstanding stood at $40.5 million in 2021, then changed by 0.0% to $40.5 million in 2022, then changed by 0.0% to $40.5 million in 2023, then changed by 0.0% to $40.5 million in 2024, then crashed by 50.72% to $20.0 million in 2025.
  • Business Quant data shows Shares Outstanding for PAHC at $20.0 million in Q4 2025, $40.5 million in Q3 2025, and $20.4 million in Q2 2025.